|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received April 13, 2007
Revised May 2, 2007
Accepted after revision May 2, 2007
1 University of Texas Medical Branch
2 Utsunomiya University
* To whom correspondence should be addressed. E-mail: blrasmus{at}utmb.edu.
The mammalian target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK) and mTOR are important nutrient and energy sensing and signalling proteins in skeletal muscle. AMPK activation decreases muscle protein synthesis by inhibiting mTOR signalling to regulatory proteins associated with translation initiation and elongation. On the other hand, essential amino acids (leucine in particular) and insulin stimulate mTOR signalling and protein synthesis. We hypothesized that anabolic nutrients would be sensed by both AMPK and mTOR resulting in an acute and potent stimulation of human skeletal muscle protein synthesis via enhanced translation initiation and elongation. We measured muscle protein synthesis and mTOR-associated upstream and downstream signalling proteins in young male subjects (N=14) using stable isotopic and immunoblotting techniques. Following a 1st muscle biopsy, subjects in the Nutrition group ingested a leucine enriched essential amino acid-carbohydrate mixture (EAC). Subjects in the Control group did not consume nutrients. A 2nd biopsy was obtained 1 hr later. Ingestion of EAC significantly increased MPS, modestly reduced AMPK phosphorylation, and increased Akt/PKB and mTOR phosphorylation (P<0.05). mTOR signalling to its downstream effectors (S6K1 and 4E-BP1 phosphorylation status) was also increased (P<0.05). In addition, eEF2 phosphorylation was significantly reduced (P<0.05). Protein synthesis and cell signalling (phosphorylation status) was unchanged in the Control group (P>0.05). We conclude that anabolic nutrients alter the phosphorylation status of both AMPK and mTOR-associated signalling proteins in human muscle in association with an increase in protein synthesis not only via enhanced translation initiation but also through signalling promoting translation elongation.
This article has been cited by other articles:
![]() |
E. I. Glover, B. R. Oates, J. E. Tang, D. R. Moore, M. A. Tarnopolsky, and S. M. Phillips Resistance exercise decreases eIF2B{varepsilon} phosphorylation and potentiates the feeding-induced stimulation of p70S6K1 and rpS6 in young men Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2008; 295(2): R604 - R610. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Wilkinson, S. M. Phillips, P. J. Atherton, R. Patel, K. E. Yarasheski, M. A. Tarnopolsky, and M. J. Rennie Differential effects of resistance and endurance exercise in the fed state on signalling molecule phosphorylation and protein synthesis in human muscle J. Physiol., August 1, 2008; 586(15): 3701 - 3717. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Drummond, H. C. Dreyer, B. Pennings, C. S. Fry, S. Dhanani, E. L. Dillon, M. Sheffield-Moore, E. Volpi, and B. B. Rasmussen Skeletal muscle protein anabolic response to resistance exercise and essential amino acids is delayed with aging J Appl Physiol, May 1, 2008; 104(5): 1452 - 1461. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Morrison, D. Hara, Z. Ding, and J. L. Ivy Adding protein to a carbohydrate supplement provided after endurance exercise enhances 4E-BP1 and RPS6 signaling in skeletal muscle J Appl Physiol, April 1, 2008; 104(4): 1029 - 1036. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Thomson, C. A. Fick, and S. E. Gordon AMPK activation attenuates S6K1, 4E-BP1, and eEF2 signaling responses to high-frequency electrically stimulated skeletal muscle contractions J Appl Physiol, March 1, 2008; 104(3): 625 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Dreyer, M. J. Drummond, B. Pennings, S. Fujita, E. L. Glynn, D. L. Chinkes, S. Dhanani, E. Volpi, and B. B. Rasmussen Leucine-enriched essential amino acid and carbohydrate ingestion following resistance exercise enhances mTOR signaling and protein synthesis in human muscle Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E392 - E400. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |